Qian Lu

机构：Central South University, Xuzhou Medical College, Chinese PLA General Hospital, Shenzhen Center for Disease Control and Prevention, Marine Biology Institute of Shandong Province, Marine Biomedical Research Institute of Qingdao, Beijing Tsinghua Chang Gung Hospital, Second Xiangya Hospital of Central South University, Education Department of Hunan Province, Ocean University of China, Qiqihar Medical University, Tsinghua University · ORCID：0000-0002-3104-8192

发表论文 67 篇 · 总被引 1468 次 · h-index 21

代表论文

• Association between fibrinogen‐to‐albumin ratio and prognosis of patients with heart failure (2023 · European Journal of Clinical Investigation · 被引 35)
• Sirt1-mediated deacetylation of PGC-1α alleviated hepatic steatosis in type 2 diabetes mellitus via improving mitochondrial fatty acid oxidation (2024 · Cellular Signalling · 被引 26)
• Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress (2024 · Chemico-Biological Interactions · 被引 25)
• Both epilepsy and anti‐seizure medications affect bone metabolism in children with self‐limited epilepsy with centrotemporal spikes (2023 · Epilepsia · 被引 15)
• Reactive oxygen species-responsive prodrug nanomicelle-functionalized Lactobacillus rhamnosus probiotics for amplified therapy of ulcerative colitis (2025 · Materials Horizons · 被引 11)
• Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysis (2024 · Orphanet Journal of Rare Diseases · 被引 11)